Faeth to present PIKTOR breast cancer data comparing multi-node cancer treatments
Faeth Therapeutics will present preclinical PIKTOR findings at ESMO 2026, including combinations with endocrine therapies and direct comparisons with gedatolisib in breast cancer models. The research supports an ongoing Phase 1b/2 trial, but human efficacy results in breast cancer are not yet available.